CLINICAL_TRIALS
trial_result
· 2025-01-13
Clinical Trial Update: Standard-Dose Combination Chemotherapy or High-Dose Combination Chemotherapy and Stem Cell Transplant in Treating Patients with Relapsed or Refractory Germ Cell Tumors [Phase 3]
Summary
This entry describes a Phase 3 trial comparing standard-dose versus high-dose combination chemotherapy with stem cell transplant for relapsed or refractory germ…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Alliance for Clinical Trials in Oncology | Conditions: Germ Cell Tumor, Teratoma | Phase 3 | Status: ACTIVE_NOT_RECRUITING